Navigation Links
Diabetes Research Institute Tests BioHub Mini Organ to Restore Natural Insulin Production in Type 1 Diabetes
Date:3/5/2013

pment of a mini organ would mimic the native pancreas and restore the natural metabolic function of insulin release in immediate response to blood sugar levels-something currently unavailable to patients with diabetes," said Jay Skyler , M.D., deputy director of clinical research and academic programs at the DRI.

"If we can identify an optimal place within the body to place a BioHub, then I believe this disease is totally reversible, which has been the DRI's ultimate goal since our inception," adds Luca Inverardi, M.D., deputy director of translational research.

The components that comprise the BioHub are in various stages of development and testing, with pre-clinical trials currently underway. Research on the DRI BioHub platform is supported through numerous sources, including but not limited to the Diabetes Research Institute Foundation, JDRF, The Leona M. and Harry B. Helmsley Charitable Trust, National Institutes of Health, NIH Small Business Innovation Research (SBIR), University of Miami, pharmaceutical companies, both foreign and domestic, and additional corporate and philanthropic partners. For more information on the development of the BioHub, visit www.DiabetesResearch.org/BioHub.

About the Diabetes Research Institute
The Diabetes Research Institute leads the world in cure-focused research. As the largest and most comprehensive research center dedicated to curing diabetes, the DRI is aggressively working to shrink the timeline toward the discovery of a biological cure for this disease. 

The DRI has made significant contributions to the field of diabetes, pioneering many of the techniques used in diabetes centers around the world. Having already shown that diabetes can be reversed through islet transplantation, the DRI is building upon these promising outcomes by bridging cell-based therapies with emerging technologies. The DRI al
'/>"/>

SOURCE Diabetes Research Institute Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015  PAREXEL International Corporation (NASDAQ: ... and Fiscal Year 2015 on Wednesday, August 5 th , ... will be available on PAREXEL,s website at www.PAREXEL.com ... PAREXEL will host a conference call and live webcast ... 2015 to discuss the results.  To access the webcast, visit ...
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
(Date:7/7/2015)... , July 7, 2015 ... new generation of drugs within human and veterinary ... sales company in the United States ... Vet-CA1, its leading companion animal therapeutic. ... http://photos.prnewswire.com/prnh/20150703/228329 ) , Paccal ...
Breaking Medicine Technology:PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... Londe, M.D. Contributing Editor The outcome of many illnesses ... (ICUs) has not improved dramatically over the past decades, ... and pharmacological support of vital organ systems. Indeed, ... five days have a 20 percent risk of death ...
... level of blood oxygenation can be an essential ... in the clinical setting is often desirable. In ... technology into easily used point-of-care devices, recent products ... values., ,HemoCue, Inc., Lake Forest, Calif., says that ...
Cached Medicine Technology:Tight Glycemic Control in the ICU 2Tight Glycemic Control in the ICU 3Hemoglobin Testing at the Point of Care 2Hemoglobin Testing at the Point of Care 3
(Date:7/7/2015)... ... July 07, 2015 , ... ... today announced that TimberNook ( http://www.timbernook.com/ ) has selected the agency ... and marketing launch package for new camp providers. TimberNook is a nature-based ...
(Date:7/7/2015)... and Wellesley, MA (PRWEB) , ... July 07, ... ... National Institute of Whole Health (NIWH) have jointly announced a partnership focused ... addressing unsolved, chronic medical case studies. The study will be conducted with NIWH ...
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys in ... new website, the Invokana Ketoacidosis Lawsuit Center . The website provides information ... resource for persons wishing to learn more about Invokana lawsuits for kidney problems, ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... and well-known patient advocate, will be recognized by the White House as a ... of the newly-launched President’s Precision Medicine Initiative, the Champions of Change program recognizes ...
(Date:7/6/2015)... , ... July 07, 2015 , ... ... in vitro universe. Increasing incidence of AIDS, advances in the molecular diagnostic technologies, ... driving forces. Recent advances in detection technologies and genetic engineering also open lucrative ...
Breaking Medicine News(10 mins):Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3
... and Women's Hospital (RBWH), Sydney struggles with an outbreak ... wards were found with a bacterium called ... ,To prevent the spread, 12 patients from burns ... were shifted to Sydney hospital and some to Brisbane's ...
... medical colleges in West Bengal continued to be paralysed ... stir against the Centre's decision to introduce OBC quota ... interns, housestaff and post graduate trainees in nine medical ... dental colleges boycotted classes as well as out patient ...
... of commonly used cholesterol-lowering drugs, used by patients ... anti-arrhythmic effect. Scientists with the ... committee evaluated about 458 sudden cardiac deaths with ... of Statin therapy. Among these about, 229 patients ...
... by Cancer Research UK says 'Teens who tried just one cigarette ... to take up smoking' //.Again after 3 years it was proved ... anti-smoking campaigns should focus on preventing children trying even one cigarette. ... of 11-year olds and 62% of 15-year olds have smoked a ...
... said it will acquire the pharmaceutical services business ... // ,The company has signed an ... CarboGen and Amcis--Solutia Inc's pharmaceutical services division, Dishman ... other assets used in the pharmaceutical services business, ...
... drug maker Ranbaxy Laboratories Limited today said the World ... Retro- Viral (ARV) products in its pre-qualification list. // ... 600mg tablets, Efavirenz 200mg capsules, Stavudine 30mg capsules, Stavudine ... ,"This is a significant development. We strongly feel that ...
Cached Medicine News:
Replacement bulb for Vibratome light system....
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades....
The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray....
... The Specimen Tray accessory fits inside the existing ... working area for tissue sectioning. Specimens are ... tray. This is a great option if ... expensive buffer, or wish to utilize the black ...
Medicine Products: